This piece featuring Sanofi authors disussing the positive impact of #AI across many different areas of a business. #pharma

🚨 New insights on rare disease innovation! Tufts CSDD Executive Director Ken Getz and Senior Fellow Marc Blaustein, present a groundbreaking framework in Pharmaceutical Executive: "ROI and Rare Disease: Retooling the ‘Gene’ Value Machine." Their strategies aim to overcome the economic and operational hurdles of personalized and genetic therapies, paving the way for more curative solutions.  📖 Dive into the full article here: https://lnkd.in/ehRgr-As 🔬 Explore more from Tufts CSDD: https://lnkd.in/eREEHzEZ #Biotech #RareDiseases #GeneticTherapies #HealthcareInnovation 

Check out our featured virtual events, including live webcasts, panel discussions, and on-demand webinars from Pharmaceutical Executive®! #RWE #RWD #FDA

Tremendously grateful to the panel of healthcare providers, patients and caregivers for recognizing Scientific Global at Pharmaceutical Executive's Apex Awards. Three nominations and three wins! Congratulations to our team and our incredible partners at Alora Pharmaceuticals, LLC and Cerapedics Inc. #TheMedEdge #ApexAwards

🏅 Exciting news! Our team, in collaboration with UCB, has proudly clinched Pharmaceutical Executive's APEX Award for our Make HStory (US HCP) campaign! We’re thrilled to see this group's innovative approach and strategic expertise make a real impact, reinforcing our commitment to advancing medical education. What makes this win even more special is that healthcare professionals chose it. Their recognition highlights how meaningful and relevant our work is to those we aim to support, with the ultimate goal of improving patient care. Here’s to continuing our mission to transform healthcare education with innovation and heart. #HealthcareExcellence #HealthcareInnovation #APEXAwards

Renée Galá has been chief operating officer at Jazz Pharmaceuticals since October 2023. During that time, she’s focused on growing the company’s product portfolio while also maintaining the culture that attracted her to Jazz in the first place. In this Q&A the COO discusses her approach to the role and how it plays into the company’s overall goals.💬🗨️

The survey is part of an initiative from GSK to improve these gaps.

A recent report shows that the global #radiopharmaceutical market is on track to reach $26.5 billion by 2031. At Ratio, we're at the forefront of this growing field, developing therapies with life-changing potential. Read this reporting from Pharmaceutical Executive to discover why targeted radiopharmaceuticals are the future of oncology #investment: https://lnkd.in/e67-a6tb